It is therefore conceivable, that loss of functional p53 either due to mutations or its increased mdm2-mediated degradation caused by deregulated signaling pathways in glioblastoma (i.e. loss of PTEN, enhanced PI3K-signaling, for reviewing see [10]) increases a tumor-promoting activity of Survivin. The gene discussed is BIRC5; the disease is neoplasm.